Impact of metformin on pregnancy outcomes in overweight wome
Phase 3
Recruiting
- Conditions
- Pregnancy outcomes in overweight pregnancies.
- Registration Number
- IRCT20190716044229N1
- Lead Sponsor
- Oroumia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 350
Inclusion Criteria
Maternal age >=16 years
Singelton pregnancy
Body mass index: 25<=BMI<30
Negative history of Diabetes Mellitus
Negative history of previous medical conditions
Gestational age between 12 & 16 weeks
Exclusion Criteria
Multiple gestation
Positive history of general medical conditions (e.g. diabetes)
BMI<25 or >=30
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of fetal macrosomia. Timepoint: Post-partum. Method of measurement: Neonatal weighing scale.;Incidence of gestational diabetes mellitus. Timepoint: From gestational age 24 weeks onward. Method of measurement: Three hour glucose tolerance test.;Incidence of preeclampsia. Timepoint: Fromgestational age 20 weeks onward. Method of measurement: Measurement of blood pressure and relevant laboratory analyses.;Gestational weight gain monitoring. Timepoint: From baseline until delivery. Method of measurement: Weighing scale.
- Secondary Outcome Measures
Name Time Method